NinePointTwo Capital LLC - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
NinePointTwo Capital LLC ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$193
-17.5%
17,6770.0%0.08%
-13.2%
Q2 2023$234
-11.7%
17,677
-9.4%
0.09%
-9.0%
Q1 2023$265
-99.9%
19,510
+23.7%
0.10%
-17.4%
Q3 2022$300,000
-7.4%
15,7730.0%0.12%
+7.1%
Q2 2022$324,000
-5.5%
15,773
+47.7%
0.11%
+21.5%
Q1 2022$343,00010,6780.09%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$52,174,00019.87%
MPM BioImpact LLC 1,745,943$33,260,0007.88%
Boxer Capital, LLC 2,154,058$41,035,0002.31%
TANG CAPITAL MANAGEMENT LLC 937,500$17,859,0002.19%
RA Capital Management 4,417,259$84,149,0001.80%
BVF INC/IL 1,810,835$34,496,0001.42%
Zebra Capital Management LLC 12,271$234,0000.89%
Integral Health Asset Management, LLC 195,000$3,715,0000.72%
Prairiewood Capital, LLC 32,269$615,0000.51%
DAFNA Capital Management LLC 97,560$1,859,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders